Showing results (71-80 of 110) with videos related to

Sort By:
Pageof 11
Journal for Immunotherapy of Cancer|December 25, 2025
Influence of time-of-day of graft infusion on allogeneic hematopoietic stem cell transplantation outcomes: a validation cohort studyChiara Bernardi, Amandine Pradier, Stavroula Masouridi-Levrat, et al.
NPJ Digital Medicine|November 18, 2025
Enhancing post-kidney transplant prognostication: an interpretable machine learning approach for longitudinal outcome predictionBowen Fan, Manuel Schürch, Yuan Tian, et al.
Molecular Ecology|September 27, 2017
The HLA-B landscape of Africa: Signatures of pathogen-driven selection and molecular identification of candidate alleles to malaria protectionAlicia Sanchez-Mazas, Viktor Černý, Da Di, et al.
Cancer Research Communications|July 23, 2024
A First-in-Human Phase I Clinical Study with MVX-ONCO-1, a Personalized Active Immunotherapy, in Patients with Advanced Solid TumorsRémi Vernet, Eugenio Fernandez, Denis Migliorini, et al.
Transplantation Direct|November 11, 2016
Human Cytomegalovirus Infection Enhances NK Cell Activity In VitroAstrid Tschan-Plessl, Martin Stern, Laurent Schmied, et al.
Blood Advances|August 27, 2021
Analysis of biological models to predict clinical outcomes based on HLA-DPB1 disparities in unrelated transplantationStéphane Buhler, Helen Baldomero, Sylvie Ferrari-Lacraz, et al.
Experimental Hematology|June 26, 2007
Regulatory T-cell recovery in recipients of haploidentical nonmyeloablative hematopoietic cell transplantation with a humanized anti-CD2 mAb, MEDI-507, with or without fludarabineJuanita Shaffer, Jean Villard, Terry K Means, et al.
Transplantation|June 8, 2015
Protection From Varicella Zoster in Solid Organ Transplant Recipients Carrying Killer Cell Immunoglobulin-Like Receptor B HaplotypesLaurent Schmied, Grzegorz Terszowski, Asensio Gonzalez, et al.
Plos One|August 27, 2013
The clinical relevance of pre-formed anti-HLA and anti-MICA antibodies after cord blood transplantation in childrenMarc Ansari, Chakradhara Rao S Uppugunduri, Sylvie Ferrari-Lacraz, et al.
NPJ Vaccines|April 28, 2020
Rapid dose-dependent Natural Killer (NK) cell modulation and cytokine responses following human rVSV-ZEBOV Ebolavirus vaccinationDavid Pejoski, Casimir de Rham, Paola Martinez-Murillo, et al.
Pageof 11